FDA to Review Post-Market Safety Checks
137276
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way the agency monitors safety risks of medicines after they  hit the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
145921
With the stunning recall of a popular pain medication last week and the impact it had on patients, the stock market and its manufacturer, it may be worthwhile to review how drugs get to market and how safety data are gathered.
214469
Medicines watchdogs are reviewing safety data for an entire class of drugs taken by millions of patients with arthritis and severe pain after the worldwide withdrawal of Merck&#39;s Vioxx last week.
120086
The US Food and Drug Administration (FDA) is considering the implementation of new regulations to improve the safety of farm eggs in order to reduce the number of illnesses caused by salmonella.
258697
The US Food and Drug Administration, facing a barrage of criticism from both within and outside the agency, announced plans Friday to improve the safety of drugs after they have been approved.
462803
Description: Faced with a series of major lapses in drug safety, the Food and Drug Administration announces new measures to rectify the situation.
546689
The Food and Drug Administration said yesterday it will create an independent drug safety board -- as critics have demanded -- that would quickly direct the agency how to respond to drugs on the market that are suspected to be unsafe.
270368
Merck &amp; Co.&#39;s recall of the Vioxx painkiller shows why the US Food and Drug Administration needs its safety monitors to be independent of those who approve new medicines, FDA scientist David J. Graham told a Senate hearing.
272549
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration said on Tuesday it was creating a new drug  safety board to improve the monitoring of medicines already in  the marketplace, a response to charges the agency has failed to  protect the public from dangerous side effects.
91514
A veteran U.S. Food and Drug  Administration scientist will unveil new data on Thursday  before an expert panel charged with determining whether pain  relievers similar to Merck & Co. Inc.'s now-withdrawn Vioxx  should remain on the market.
517308
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration will ask the Institute of Medicine to study the  agency's safety monitoring of medicines already on the market,  Acting FDA Commissioner Lester Crawford said on Friday.
598332
The FDA will review its new cholesterol drug.
280625
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol medicine Vytorin after a study showed it was no better than a generic drug in preventing the build-up of fatty plaque.
171919
U.S. regulators said on Friday they  would review whether to take action over Merck & Co Inc's   and Schering-Plough Corp's  popular cholesterol  medicine Vytorin after a study showed it was no better than a  generic drug in preventing the build-up of fatty plaque.
226044
U.S. health officials said on Friday  they would review whether to take regulatory action over Merck  & Co Inc  and Schering-Plough's  cholesterol  medicine Vytorin following the drug's failure to work better  than a generic drug in a study of plaque build-up in neck  arteries.
579654
U.S. regulators said on Friday they were reviewing the safety of Allergan Inc's  Botox and a competing product, after reports of deaths and serious reactions in some patients.
185982
The editors of the Journal of the American Medical Association (JAMA) are calling for an end to the US Food and Drug Administration&#39;s (FDA) role in post-market monitoring of the safety of drugs it approves.